How is Melanoma graded and what does the grade mean

MelanomaMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

How Melanoma is Graded and What It Means

Great question! Melanoma grading is actually different from how many other cancers are graded. Let me explain how it works and why it matters for your care.

The Melanoma Grading System

Unlike some cancers that use a simple "Grade 1, 2, 3" system, melanoma uses several different measurements to describe how serious it is. According to the NCCN Guidelines for Patients: Melanoma, these key factors include:

1. Breslow Thickness

This is the primary measurement—it tells doctors how deep the melanoma has grown into your skin layers, measured in millimeters. Think of it like measuring how far down a tree the damage goes:

  • Thinner melanomas (less than 1 mm) generally have a better outlook
  • Thicker melanomas (more than 4 mm) are more serious and more likely to spread

2. Mitotic Rate

This measures how many cancer cells are actively dividing and growing in the dermis (the deeper layer of skin). A higher mitotic rate means the cancer cells are multiplying faster, which is concerning.

3. Ulceration

This refers to whether the melanoma has broken through the skin surface, creating an open sore. If ulceration is present, it indicates a more aggressive melanoma.

4. Other Important Features

The NCCN Guidelines also note that doctors evaluate:

  • Clark level (how deep into skin layers the cancer extends)
  • Lymphocytic infiltration (whether immune cells are fighting the cancer)
  • Microsatellites (tiny tumor deposits near the main tumor that can only be seen under a microscope)

What the Grade Means: The Staging System

Rather than a simple "grade," melanoma is classified into five stages (0 through 4), which better predict how the cancer will behave:

According to the NCCN Guidelines, "The lower the number, the earlier the stage and the easier the melanoma is to treat with fewer treatments." Here's what each stage generally means:

  • Stage 0: Cancer is only in the top skin layer (in situ)
  • Stages 1-2: Localized melanoma (confined to the original area)
  • Stage 3: Regional melanoma (has spread to nearby lymph nodes or skin)
  • Stage 4: Metastatic melanoma (has spread to distant parts of the body)

Why This Matters for Your Care

The NCCN Guidelines emphasize that "Treatment for melanoma depends on the extent of the cancer known as its stage." Your specific grade and stage determine:

  • What treatment you'll receive (surgery, immunotherapy, targeted therapy, etc.)
  • Whether you need additional testing (like lymph node biopsies or imaging)
  • Your follow-up care plan (how often you'll be monitored)
  • Adjuvant therapy options (additional treatment after surgery to reduce recurrence risk)

Important Context

The good news: "More than 3 in 4 melanomas are found early — before they have spread — and when they're easier to treat." Early detection makes a significant difference in outcomes.

Questions to Ask Your Care Team

Since grading and staging are crucial for your treatment plan, consider asking:

  1. What is my specific Breslow thickness, and what does that mean for my prognosis?
  2. Are there any other features (ulceration, mitotic rate, microsatellites) that affect my treatment plan?
  3. What stage is my melanoma, and how does that determine my treatment options?
  4. Will I need additional testing like sentinel lymph node biopsy or imaging?
  5. What adjuvant (follow-up) therapy options are recommended for my specific grade and stage?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: